Sign inJoin waitlistJoin the waitlist

Talicia Savage

Assistant Professor · Univ of Utah Sch of Med

Credentials: · · · · ·

History

Univ of Utah Sch of Med
Present

Medical Oncology
2024–2026
Univ of Utah Sch of Med
2023–2024
Internal Medicine
University of Washington-Seattle Campus
2020–2023
Albert Einstein College of Medicine
2016–2020

Research

Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy
PLoS ONE · 2016 · 280 citations
Expression of NF-κB p50 in tumor stroma limits the control of tumors by radiation therapy
PLoS ONE · 2012 · 94 citations
Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy
Oncotarget · 2016 · 83 citations

MC
Marka Crittenden
7 papers
Kristina Young
4 papers · 4 as a resident
Alli Straubhar
1 paper · 1 as a fellow
Carlo Bifulco
1 paper
Chandan Guha
1 paper
CH
Chet Hammill
1 paper
HX
Hong Xiao
1 paper
KS
Kiera Sibbald
1 paper · 1 as a resident
Lesley Lomo
1 paper
PH
Paul Hansen
1 paper
Rachel Issaka
1 paper
Ronald Wolf
1 paper

Clinical trials

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2026–2028
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Site PI · Recruiting · Phase 3
NRG Oncology
2025–2034